215 related articles for article (PubMed ID: 20605768)
1. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database.
Vena GA; Altomare G; Ayala F; Berardesca E; Calzavara-Pinton P; Chimenti S; Giannetti A; Girolomoni G; Lotti T; Martini P; Mazzaglia G; Peserico A; Puglisi Guerra A; Sini G; Cassano N; Cricelli C
Eur J Dermatol; 2010; 20(5):593-8. PubMed ID: 20605768
[TBL] [Abstract][Full Text] [Related]
2. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
3. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
[TBL] [Abstract][Full Text] [Related]
4. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
Shapiro J; Cohen AD; David M; Hodak E; Chodik G; Viner A; Kremer E; Heymann A
J Am Acad Dermatol; 2007 Apr; 56(4):629-34. PubMed ID: 17157411
[TBL] [Abstract][Full Text] [Related]
5. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.
Morgan C; Lunt M; Bunn D; Scott DG; Symmons DP
Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539
[TBL] [Abstract][Full Text] [Related]
6. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
7. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?
Lotti T; Hercogova J; Prignano F
Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818
[TBL] [Abstract][Full Text] [Related]
8. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics.
Christophers E; Barker JN; Griffiths CE; Daudén E; Milligan G; Molta C; Sato R; Boggs R
J Eur Acad Dermatol Venereol; 2010 May; 24(5):548-54. PubMed ID: 19874432
[TBL] [Abstract][Full Text] [Related]
9. A clinical survey of psoriasis in Italy: 1st AISP report. Interdisciplinary Association for the Study of Psoriasis.
Finzi AF; Benelli C
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):125-9. PubMed ID: 9553908
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities associated with psoriasis: an experience from the Middle East.
Al-Mutairi N; Al-Farag S; Al-Mutairi A; Al-Shiltawy M
J Dermatol; 2010 Feb; 37(2):146-55. PubMed ID: 20175849
[TBL] [Abstract][Full Text] [Related]
11. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of psoriasis following obstructive sleep apnea: a longitudinal population-based study.
Yang YW; Kang JH; Lin HC
Sleep Med; 2012 Mar; 13(3):285-9. PubMed ID: 22285106
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of comorbidities in psoriasis.
Naldi L; Mercuri SR
Dermatol Ther; 2010; 23(2):114-8. PubMed ID: 20415817
[TBL] [Abstract][Full Text] [Related]
14. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.
Velez NF; Wei-Passanese EX; Husni ME; Mody EA; Qureshi AA
Arch Dermatol Res; 2012 Jan; 304(1):7-13. PubMed ID: 21904925
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis: cardiovascular risk factors and other disease comorbidities.
Wu Y; Mills D; Bala M
J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and comorbidity of psoriasis in children.
Augustin M; Glaeske G; Radtke MA; Christophers E; Reich K; Schäfer I
Br J Dermatol; 2010 Mar; 162(3):633-6. PubMed ID: 19922529
[TBL] [Abstract][Full Text] [Related]
17. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological study of psoriasis in the national health insurance database in Taiwan.
Chang YT; Chen TJ; Liu PC; Chen YC; Chen YJ; Huang YL; Jih JS; Chen CC; Lee DD; Wang WJ; Lin MW; Liu HN
Acta Derm Venereol; 2009; 89(3):262-6. PubMed ID: 19479122
[TBL] [Abstract][Full Text] [Related]
19. Incidence of arthritis in a prospective cohort of psoriasis patients.
Eder L; Chandran V; Shen H; Cook RJ; Shanmugarajah S; Rosen CF; Gladman DD
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):619-22. PubMed ID: 21452273
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities significantly impact patients' preferences for psoriasis treatments.
Schmieder A; Schaarschmidt ML; Umar N; Terris DD; Goebeler M; Goerdt S; Peitsch WK
J Am Acad Dermatol; 2012 Sep; 67(3):363-72. PubMed ID: 22015150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
